Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 15/20 | 0.62 |
| ▸ | PPARG | P37231 | 13/20 | 0.62 |
| ▸ | PPARD | Q03181 | 3/20 | 0.46 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | IGF2BP2 | Q9Y6M1 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6356402 | 0.87 | PPARA (0.50) | PPARAPPARGPPARD | |
| SCHEMBL6359007 | 0.85 | PPARA (0.61) | PPARAPPARGPPARD | |
| SCHEMBL6359263 | 0.85 | PPARG (0.84) | PPARAPPARGPPARDSOAT1 | |
| SCHEMBL6359267 | 0.85 | PPARG (0.84) | PPARAPPARGPPARDSOAT1 | |
| SCHEMBL6359939 | 0.85 | PPARG (0.84) | PPARAPPARGPPARDSOAT1 | |
| SCHEMBL6364752 | 0.84 | PPARA (0.63) | PPARAPPARGPPARDMEN1GAA | |
| SCHEMBL6364676 | 0.84 | PPARA (0.62) | PPARAPPARGPPARD | |
| SCHEMBL10889485 | 0.84 | PPARG (0.50) | PPARAPPARGPPARDSOAT1IGF2BP2 | |
| SCHEMBL6364698 | 0.83 | PPARA (0.58) | PPARAPPARGPPARD | |
| SCHEMBL6363531 | 0.83 | PPARA (0.61) | PPARAPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050075377-A1 | PPAR compounds | PFIZER INC | 2005-04-07 | — | — | US | disclosed |
| US-20020169192-A1 | PPAR compounds | HAYWARD CHERYL M (US) | 2002-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020169192-A1 | PPAR compounds | PPARA, PPARG, PPARD | PPARA 1/4885PPARG 2/4885PPARD 3/4885 |
| US-20050075377-A1 | PPAR compounds | PPARA, PPARG, PPARD | PPARA 1/4885PPARG 2/4885PPARD 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.